Initiative for Multipurpose Prevention Technologies (IMPT)
MPT Activities: 2010-2012(DRAFT)
Activity name / Lead / Description / Projected Outcome/Deliverable / Status / Members/ Working groupIMPT
Technical Coordination and Advisory Committee convening / CAMI/PHI
(CAMI Staff: Bethany, Kathryn;
PHI Staff: Jeff Meer.
Consultants: Polly Harrison; Alan Stone;
Tracy Salkowitz;
Subs: ARHP; Guttmacher) / Host of the initiative.
Serves as the non-aligned convener for IMPT and a forum for multidisciplinary collaboration.
Serves an on-line information hub for news and resources re MPTs and relevant innovative approaches for improved SRH.
The IMPT mobilizes cross-disciplinary collaboration to identify MPT product priorities and an action plan for development.
Through coalition member activities, IMPT also increases awareness, funding resources, and legislative and regulatory support for MPTs. / Increase global awareness, support and access for MPTs;
Organize and implement ‘MPTs 2011 Symposium’;
Develop and maintain an MPT R&D Database that tracks emerging and available MPTs;
Develop and implement 5 yr strategic plan for the IMPT; / On-going / Martha Brady
Population Council
Gina Brown
NIH, OAR
Marianne Callahan
CONRAD
Craig Cohen
UCSF
Jessica Cohen
PATH
Polly Harrison
IMPT/ AVAC
Anke Hemmerling
UCSF
Bethany Young Holt
CAMI/PHI
Maggie Kilbourne-Brook
PATH
Judy Manning
USAID
Jeff Meer
PHI
Matthew Reeves
WomanCare Global
Wayne Shields
ARHP
Alan Stone
IMPT/MEDA
Kevin Whaley
Mapp Biopharmaceutical)
IMPT 5-year Strategic plan / CAMI/PHI
(CAMI Staff: Bethany; CAMI Consultant: Tracy Salkowitz; PHI Staff: Jeff Meer and Suzanne Petroni / IMPT Advisory Committee members will work with CAMI staff and consultants to develop a phased-in 5 year strategic plan that will help advance MPT product development and access. / Develop a 5-year strategic plan for IMPT, including a plan for the sustainable delivery of existing MPTs and development of emerging technologies.
Identify priorities for action and requests for funding/support. / Draft plan complete and will be distributed to Advisory members for input .
In-person strategic planning meeting to be held in DC 2.4.2011 / IMPT Advisory Committee members (above)
Message Development / PATH
(Jessica Cohen & Maggie Kilbourne-Brook) / PATH is facilitating some initial messaging activities to help inform how MPT initiative Advisory members and key partners communicate about what we are doing with different audiences. / Defineand test core MPT messages and talking points for initiative Advisory members and key partners. / PATH selected a PR firm to work on this activity in December.
PATH to present initial messages at IMPT meeting on 2.4.2011;
Messages refined and finalized by March 1, 2011 / Jessica Cohen
Maggie K-B
Heather Boonstra Polly Harrison
Bethany YH
Kaitlin
(others TBD)
MPT Product Development Think Tank / Polly Harrison
(CAMI/ IMPT Consultant) / The TT will focus on Product Profiles that are feasible and acceptable. The Think Tank will commission working groups (WGs) to generate development strategies for each product profile / Identify priority MPT product profiles and next steps for advancing these profiles as part of the MPT initiative.
Develop a consensus on how to continue dialogues re MPT product profiles. / A proposed Think Tank (TT) organized by IMPT and AVAC is under review for funding with AVAC. / Polly Harrison,
Bethany Young Holt
Judy Manning, Alan Stone,
Kevin Whaley,
MPT Regulatory Issues / Population Council
(Martha Brady & Victor Paulusi) / Pop Council was awarded a two year USAID APS to stimulate thinking and promote problem-solving around MPT regulatory pathways by engaging and convening Thought Leaders and experts in the fields of contraception; prevention of STIs, including HIV; product development; clinical study design; and regulatory affairs to capitalize on their collective expertise to help shape regulatory processes for MPTs / Develop a “Road Map” of possible regulatory pathways as a foundation for the approval of MPTs.
Strategic engagement with regulatory authorities will include the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Stringent Regulatory Authorities (SRAs), and selected developing country regulatory agencies. / Planned convening on 1.31.2011 re Nomenclature as it pertains to regulatory issues. / Martha Brady
Victor Paulusi
Tim Farley
Polly Harrison
MPT 2011 Symposium / CAMI/PHI
(Bethany-Co Chair.
Kathryn-staff; Tracy-consultant)
ARHP (Wayne-
Co Chair; Camille- Staff) / Symposium Goal: Advance the MPT science and translate the science into practical and accessible applications
The planned 2-day, invitation only convening Symposium will be held Nov 3-5, 2011 in Washington, DC.
Participants will represent a multidisciplinary cadre of global experts working in the area of MPTs as well as those with expertise that can help advance the field (eg. donors, media, etc).
Several interrelated IMPT activities are currently underway which will help lay the foundation for the Symposium and IMPT. These activities include the Product Profile TT, the Regulatory Activity, and Messaging. / Through multidisciplinary ‘strategic dialogues’ identify product profile priorities and develop a plan of action for advancing the field
Products will provide a concrete basis for activities that foster the development of multidisciplinary networks globally and regionally to advance MPT development and access.
Encourage strategic , multidisciplinary dialogues between participants to both advance the science and translate the science into practical and accessible applications / Initial funding support from USAID; additional fund raising underway;
Planning survey distributed and analyzed (9.2010); Preliminary Symposium goals and format defined; Program Committee invited and planning schedule agreed upon; Advisory Committee invited; / Program Committee:
Bethany Young Holt (co-chair),
Wayne Shields (co-chair)
Jess Cohen
Maggie Kilbourne-Brook
Anke Hemmerling
Helen Rees
Kevin Whaley
Allen Wu
Advisory Committee: (Invited; confirmations requested by Jan 12, 2011)
Staff: Kathryn Stewart (CAMI)& Camille Harris (ARHP); Tracy Salkowitz (consultant)
MPT Product Mapping Matrices / CAMI/PHI
(Bethany & Kathryn)
Marianne Callahan /CONRAD (M’cide and devices WG Chair);
Kevin Whaley (Vaccine WG Chair) / The Multipurpose Prevention Technologies (MPTs) Product Mapping Matrices outlines available and emerging MPTs. The matrices are presented in to two main tables: MPT Microbicides and Devices Matrix and the Vaccine Matrix and are posted on the CAMI website. / An on-line database of emerging and available MPTs that will be updated every 6 months. / The WG has convened for over a year.
The database is completed and available at
A protocol has been developed to update the database every 6 months which includes the development of of an MPT product profile survey (completed) that will be distributed on-line to colleagues /experts. / Marianne Callahan
Polly Harrison
Matt Reeves
Wayne Shields
Kevin Whaley
Staff: Kathryn Stewart, Bethany Young Holt
Web/database Consultant: Elizabeth Callahan
International MPT Outreach/
Awareness
Raising / CAMI /PHI (Alan Stone -MEDSA; CAMI& IMPT consultant) / Identify well-respected leader(s) in different regions around the globe to help raise awareness and support for MPTs and serve as regional IMPT ‘hub’ coordinators / Contact key regional stakeholders and secure their support in raising awareness re MPTs in their region;
Compile and distribute ‘MPT Information Packet/Materials’ to regional supporters;
Implement long term outreach /awareness and support efforts / Alan has identified and contacted key stakeholders around the globe re MPTs as well as an invitation to support the initiative.
CAMI staff compiled MPT relevant materials into an ‘MPT Information Packet’
Packets mailed to those offering support and interest in the IMPT (see next column)
Brown bag planned re the IMPT for PHI International Health project leaders to educate re MPTs and encourage collaboration (e.g., Global Health Fellows, Agali, etc) / International MPT Supporter/IMPT ‘HUBS’
China
Allen Wu
Nanjing University
India
Nomita Chandhiok
Indian Council of Medical Research
South Africa
Glenda Gray
University of Witwatersrand
QuarraishaAbdoolKarim
Center for AIDS Research Program in South Africa
Helen Rees
RHI University of the Witwatersrand, South Africa
United Kingdom
Robert Millar
MRC Human Reproductive Sciences Unit, Edinburgh
Zimbabwe
Michael Chirenje
University of Zimbabwe
Domestic MPT Outreach/
Awareness
Raising / CAMI/Guttmacher
Heather Boonstra (Guttmacher Institute) / Identify strategies to secure support (via RFAs etc) for MPTs at the NIH and etc
Create a short statement’
on the importance of multipurpose prevention technologies (MPTs) for sign-on from organizations around the world.
This “endorsement statement” will outline the case for multipurpose prevention technologies and call on governments, donors, researchers and others to encourage the development of multipurpose technologies for the prevention of unintended pregnancy and disease. / Identify strategies to secure support (via RFAs etc) for MPTs at the NIH and etc;
Identify key US-based stakeholders with whom to inform/engage re MPTs;
Develop an ‘endorsement statement’ for MPTs that can be used to show US and global support for MPTs. / On going discussions re. strategies to engage NICHD and other potential domestic donors.
Preliminary discussions with several DC-based and CA-based stakeholders.
‘Endorsement Statement’ verbiage will be finalized upon completion of messaging activity (above) to ensure appropriate and consistent messages to target audiences.
Preliminary drafting of ‘endorsement statement’ / Heather Boonstra
Bethany YH,
Polly Harrison Tracy Salkowitz Kathryn Stewart
(others TBD)
Behavioral& Translational Science / CAMI
(Bethany &Kathryn) / CAMI is appointing small working group of behavioral scientists, translational science researchers, cultural anthropologists, and learning theory experts to bring another dimension to the IMPT discussion and help ensure successful access and support for MPTs. / Identify key strategies and principles which can be applied to the product development, regulatory issues, and message development efforts as appropriate. / Early planning stages / Invited:
Kate Morrow
Wayne Shields
Bethany Young Holt
(others TBD)
'Multipurpose Prevention 101' presentation and platform. / CAMI/ARHP
(Wayne and Camille) / Building from the outcomes of the Messaging activity (above), ARHP and CAMI will work closely with IMPT partners to develop a peer-reviewed, open access presentation to serve as a baseline platform for outreach, advocacy, and education on multipurpose prevention technologies. / Develop and make available to IMPT partners a power point presentation, MPT 3-fold brochure, and other materials to integrate into presentations etc / Pending completing of the ‘messaging’ activity. / Maggie Kilbourne-Brook
Camille Harris
Polly Harrison
Bethany Young Holt
Wayne Shields
Kathryn Stewart
(others TBD)
MPT Awareness raising and Social Networkng / CAMI/PHI / CAMI created a FACEbook page to raise awareness re MPTs. This includes a project called ‘Global Reproductive Health Dialogues’- a series of testimonials from women around the globe and their need for MPTs; a Survey to engage women re MPTs. Etc
A video on MPTs and the initiative produced. / Increase awareness, understanding and support for MPTs among different audiences / FACEbook is updated every several days with MPT related news/links.
Most recently using Twitter and will be starting a blog to be posted on Huffington Post - with blog submissions by Dr. Criag Cohen (UCSF), who will be reporting on ‘the need for MPTS from the field’- based on clinical work he does in SF and in Kenya, as well as Bethany and hopefully other global and US IMPT Advisors and supporters.
Results from Messaging activity will inform ongoing activities in this area.
MPT video has been produced and posted on CAMI website. Abroader distribution plan is being developed (eg., for distribution on FB, Twitter, and partner websites / CAMI staff
Draft (12.20.2010) 1